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Objective
A randomized, controlled, multicenter trial was undertaken in 102 patients with objective evidence
of severe acute pancreatitis to evaluate whether selective decontamination reduces mortality.
Summary Background Data
Secondary pancreatic infection is the major cause of death in patients with acute necrotizing
pancreatitis. Controlled clinical trials to study the effect of selective decontamination in such
patients are not available.
Methods
Between April 22, 1990 and April 19, 1993, 102 patients with severe acute pancreatitis were
admitted to 16 participating hospitals. Patients were entered into the study if severe acute
pancreatitis was indicated, on admission, by multiple laboratory criteria (Imrie score 2 3) and/or
computed tomography criteria (Balthazar grade D or E). Patients were randomly assigned to
receive standard treatment (control group) or standard treatment plus selective decontamination
(norfloxacin, colistin, amphotericin; selective decontamination group). All patients received full
supportive treatment, and surveillance cultures were taken in both groups.
Results
Fifty patients were assigned to the selective decontamination group and 52 were assigned to the
control group. There were 18 deaths in the control group (35%), compared with 1 1 deaths (22%)
in the selective decontamination group. (adjusted for Imrie score and Balthazar grade: p = 0.048).
This difference was mainly caused by a reduction of late mortality (>2 weeks) due to significant
reduction of gram-negative pancreatic infection (p = 0.003). The average number of laparotomies
per patient was reduced in patients treated with selective decontamination (p < 0.05). Failure of
selective decontamination to prevent secondary gram-negative pancreatic infection with
subsequent death was seen in only three patients (6%) and transient gram-negative pancreatic
infection was seen in one (2%). In both groups of patients, all gram-negative aerobic pancreatic
infection was preceded by colonization of the digestive tract by the same bacteria.
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Conclusion
Reduction of gram-negative colonization of the digestive tract, preventing subsequent pancreatic
infection by means of selective decontamination, significantly reduces morbidity and mortality in
patients with severe acute necrotizing pancreatitis.
Despite improvement in surgical strategies, the mor-
tality of patients with acute necrotizing pancreatitis re-
mains high, between 20% and 70%.1-8 Infection of pan-
creatic necrosis is the most important cause of late mor-
tality in severe acute pancreatitis.37,9-'3 The value of
prophylactic antibiotics has not been clearly demon-
strated in patients with severe acute pancreatitis and pos-
sibly is due to patient selection, inadequate spectrum, in-
sufficient doses, or tissue penetration.12"14-'7
Intravenous antibiotics, which penetrate the pancreas-
blood barrier, may not protect the necrotic nonperfused
areas in and around the inflamed pancreas against infec-
tion. The route by which sterile pancreatic necrosis be-
comes infected is not yet known. Experimental studies
and clinical observations have suggested that transloca-
tion of bacteria toward the pancreas occurs hematoge-
nously,1819 transmurally through the colon,20-22 via lym-
phogenous routes,20,23 via ascites,19,23 and through bile24
and duodenal chyme reflux.25 Because gram-negative
bacteria-predominantly isolated from the pancreatic
necrosis-are of enteric origin, the source of the translo-
cating bacteria probably is the intestine.2790422232627
Prevention oftranslocation by intraluminal elimination
of aerobic gram-negative micro-organisms in the intesti-
nal tract may be an effective method to prevent pancre-
atic necrosis from becoming infected. In a controlled ex-
perimental study on rats with bile-salt-induced pancre-
atitis, Lange et al. demonstrated a significant reduction
of mortality in rats treated with intestinal lavage and in-
traluminal instillation of kanamycin.'9 Isaji et al. re-
cently demonstrated in mice fed a choline-deficient, ethi-
onine-supplemented diet to induce pancreatitis that oral
antibiotics caused a threefold reduction of infected ne-
crosis and a significantly improved survival.28
Several clinical studies have demonstrated that selec-
tive decontamination effectively eliminates aerobic
gram-negative bacteria from the intestinal tract and
sometimes reduces gram-negative septic complications
in intensive care unit patients. However, results regard-
29-34ing reduction of mortality are conflicting. Thi ra
domized, controlled clinical trial was undertaken to eval-
uate whether selective decontamination reduces mortal-
ity in patients with objective evidence of severe acute
pancreatitis.
METHODS
Between April 22, 1990 and April 19, 1993, 102 pa-
tients with objective clinical signs ofsevere acute pancre-
atitis were admitted to 16 participating hospitals. The di-
agnosis of acute pancreatitis had been established on the
basis of clinical examination and elevated plasma levels
ofamylase (> 1000 international units/L), or at diagnos-
tic laparotomy (ten patients). All patients were scored ac-
cording to multiple laboratory criteria (Imrie score)35
and contrast-enhanced computed tomography (CE-CT)
examinations were used to classify disease severity (Bal-
thazar grades)36 within 48 hours of hospital admission
(Table 1).
Patients were included in the study ifthe following cri-
teria were met: severe pancreatitis was indicated by three
or more points according to the Imrie score and/or CT
findings corresponding with Balthazar grade D or E.
Findings at diagnostic laparotomy were not accepted
as an inclusion criteria. Exclusion criteria were defined
as follows: allergy to one ofthe antibiotics ofthe selective
decontamination regimen; younger than 18 years of age;
postoperative pancreatitis after pancreatic surgery; and
bacteriologically proven infected necrosis at the time of
randomization. The attending clinician obtained in-
formed consent from the patient or relatives.
Patients who satisfied the criteria were randomly as-
signed to receive standard treatment (control group) or
the same standard treatment plus selective decontami-
nation (selective decontamination group). A 24-hour
randomization service was available to randomize pa-
tients with stratification per center. Follow-up CT scans
were repeated every week until discharge or death. The
study was approved by the ethics committees of the par-
ticipating hospitals.
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Control Group: Standard Treatment
A nasogastric tube was always inserted. Intravenous
crystalloid solutions were given according to clinical re-
quirements. Oxygen therapy, based on arterial blood gas
analysis, was administered by face mask and was re-
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>55 years
<2.00 mmol/l
> 16 mmol/I
>600 U/I
> 10 mmol/l
>15 109/1
<32 g/l
<60 mm Hg (7.5 kPa)
Degree of disease severity according to Balthazar classificationt
Grade A
Grade B
Grade C
Grade D
Grade E
Normal pancreas.
Focal or diffuse enlargement of the pancreas
(including contour irregularities,
nonhomogeneous attenuation of the
gland, dilatation of the pancreatic duct,
and foci of small fluid collections within the
gland, as long as there is no evidence of
peripancreatic disease).
Intrinsic pancreatic abnormalities associated
with haziness and streaky densities
representing inflammatory changes in the
peripancreatic fat.
As C plus single ill-defined fluid collection
(phlegmon) in or adjacent to the pancreas.
As C plus two or multiple, poorly defined fluid
collections or the presence of gas in or
adjacent to the pancreas.
LDH = lactate dehydrogenase; WBC = white blood cell count; PaO2 = arterial oxy-
gen concentration.
* The Imrie score equals the number of separate criteria present (minimum: 0; maxi-
mum: 8).
t Computed tomography scan with use of oral (1/2 hour before) and intravenous
contrast (rapid intravenous drip).
placed by assisted ventilation if the patient developed
respiratory insufficiency. Cultures from the oropharynx,
rectum, sputum, gastric content, and urine were taken
on admission to the hospital and twice a week until dis-
charge. If fever (.39 C) was present, blood cultures were
taken. Except for urine, qualitative semiquantitative
bacteriologic analysis was performed routinely on all cul-
tures. Cultures of pancreatic necrosis and ascites were
obtained at laparotomy or by means of ultrasonography
or CT-guided percutaneous puncture, as described by
Gerzoffet al.,'0 if there was clinical suspicion of infected
pancreatic necrosis. Patients underwent surgery if an ul-
trasongographic or CT-guided puncture showed pres-
ence of bacteria or if the condition was deteriorating de-
spite aggressive supportive treatment. Surgery was per-
formed either by transverse or median laparotomy. If
repeated laparotomies were foreseen, a laparostomy, i.e.,
a ventral open packing ofthe abdominal cavity, was cre-
ated.2 Antibiotics were prescribed according to the anti-
biogram only in the presence of concurrent infection.
Enteral feeding was replaced by total parenteral nutrition
only if recurrent gastric retention was present.
Selective Decontamination Group:
Standard Treatment with Adjuvant
Selective Decontamination
Patients randomized to the selective decontamination
group received the same treatment as the control group
with the addition of selective decontamination. The se-
lective decontamination regimen consisted of oral ad-
ministration of colistin sulfate (200 mg), amphotericin
(500 mg) and norfloxacin (Noroxin, Merck & Co., West
Point, PA; 50 mg) every 6 hours. A sticky paste contain-
ing 2% of the three selective decontamination drugs was
smeared along the upper and lower gums every 6 hours
and at the tracheostomy, if present. The aforementioned
daily dose also was given in a rectal enema every day. A
short-term systemic prophylaxis of cefotaxime sodium
(Claforan, Hoechst-Roussel Pharm., Inc., Somerville,
NJ; 500 mg) was given every 8 hours until gram-negative
bacteria were eliminated from the oral cavity and rec-
tum. Selective decontamination was discontinued as
soon as the risk of acquiring a new infection was ab-
sent-i.e., the patient was extubated and without supple-
mentary oxygen therapy or infusions, on regular oral
diet, and mobilized on the ward.
Statistical Analysis
Power calculations at the phase of trial design, assum-
ing a decrease in mortality from 50% to 25%, led to a
total number of 154 patients to be included (alpha = 0.05
[two-sided] and beta = 0.10).
Because the annual accrual rate was much less than
expected, after 2 years it was decided to limit the size of
the trial to 100 evaluable patients, thereby reducing the
power to 80% at one-sided testing. This decision was
made without consideration of the accumulating out-
comes.
Percentages were compared by the Fisher exact test or
the chi square test, if appropriate. Continuous data were
compared by the Mann-Whitney U test. For mortality,
which was the major endpoint in this study, multivariate
analysis (logistic regression37) at entry into the study, al-
lowing for Imrie score and Balthazar grade, was per-
formed to obtain a higher level ofprecision in comparing
treatment groups. Two-sided p values of0.05 or less were
Table 1. PROGNOSTIC SYSTEMS USED TO
SELECT PATIENTS FOR INCLUSION
IN THE TRIAL
Multiple laboratory criteria (Imrie score)*
Age
Serum uncorrected calcium
Serum urea
LDH
Blood glucose (no diabetes)
WBC
Serum albumin
PaO2
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considered statistically significant. Follow-up was con-
tinued until death or discharge from the hospital. Table 2. BASELINE CHARACTERISTICS OFPATIENTS WITH ACUTE NECROTIZING
PANCREATITIS
RESULTS
Inclusions, Exclusions, and Withdrawals
Of the 109 patients randomized into the study, 2 (se-
lective decontamination: n = 1; control: n = 1) were ex-
cluded because ofperioperatively proven infected necro-
sis immediately (< 1 hour) after randomization and be-
fore treatment was started. In addition, five patients
(selective decontamination: n = 3; control: n = 2) were
withdrawn from the study because the clinical diagnosis
was found to be erroneous (one patient with streptococ-
cal sepsis, one patient with an acute aortic occlusion im-
mediately after coronary bypass surgery, one patient
with a ruptured pancreatic pseudocyst, one patient with
chronic pancreatitis, and one patient with an endoscopic
retrograde cholangiopancreatograpy-induced choledo-
chus perforation). Ofthe remaining 102 patients, 50 had
been assigned to the selective decontamination group
and 52 to the control group. Inclusion scores are listed in
Table 2. Selective decontamination was started within
24 hours of randomization. Ten patients (selective de-
contamination: n = 8; control: n = 2) with severe acute
pancreatitis had to be randomized only on the basis of
the multiple laboratory criteria (Imrie score 2 3) because
their condition did not permit transport from the inten-
sive care unit to the CT scanner at that time. Of these
patients, fluid collections in or adjacent to the severely
inflamed pancreas (personal communication with the at-
tending surgeon immediately postoperatively) were
demonstrated on the first day of the study during lapa-
rotomy in eight patients and with abdominal ultrasound
in one patient. Because of these results, the Balthazar
grade was classified as grade E. In the other patient (con-
trol group; Imrie score = 3), a CT scan was performed
only after 5 days of treatment, and it demonstrated a
peripancreatic fluid collection. The latter patient also un-
derwent surgery on the first day after randomization;
however, the pancreatic loge was left untouched. The
Balthazar grade at the time of randomization was un-
available for this patient.
Comparability of Control and Selective
Decontamination Group
Both treatment groups appeared well matched for age,
sex, etiologic factors, Imrie score, and Balthazar grade.
Characteristics for both groups are listed in Table 2. The
mean Imrie score was 3.2 for both groups. Patients with
an Imrie score of 8 were not encountered in this study.
Mean age (years)
Sex
Male
Female
Etiology
Alcohol
Gallstones
Hyperparathyroidism
Blunt abdominal trauma
Postoperative
ERCP-induced
Unknown
Imrie score
0
1
2
3
4
5
6
7
8
Balthazar degree of disease
severity
Grade A
Grade B
Grade C
Grade D
Grade E
Day 1 unavailable
Selective
Decontamination
Group
(n = 50)
56 (26-91)
31
19
19
17
0
1
2
1
10
5
8
2
10
12
9
3
1
0
0
0
3
21
26
0
Control
Group
(n = 52)
55 (20-88)
29
23
12
19
2
0
2
3
14
4
7
10
6
13
6
2
4
0
0
0
4
20
27
1*
ERCP = endoscopic retrograde cholangiopancreatography.
* Computed tomography scan was performed on day 5: grade D.
Mortality
Eleven patients (22%) in the selective decontamina-
tion group died as compared with 18 patients (35%) in
the control group. This difference is not significant (p =
0.19). The 95% confidence limits of the difference (con-
trol group minus selective decontamination group) in
mortality ranges from less than 4% to more than 30%.
Survival according to treatment group is shown in Figure
1. All deaths occurred within 80 days. In each of both
groups, six patients died of multiple-organ failure with
documented sterile pancreatic necrosis. Ten patients in
the control group died ofa gram-negative pancreatic sep-
sis syndrome compared with only three such patients in
the selective decontamination group (p = 0.07). In each
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Figure 1. Overall survival according to treatment. Overall mortality rates
at 90 days: selective decontamination group = 22%; control group =
35%. Adjusted for lmrie score and Balthazar grade, p = 0.048. Difference
in mortality rates equals 13% (95% confidence limits: -4%, +30%).
group, one patient died of sepsis due to a solitary gram-
positive pancreatic infection. Gram-positive sepsis ofun-
known origin, without pancreatic infection, was the
cause ofdeath in one patient in each ofboth groups.
The Imrie score at entry into the study appeared to
correlate very strongly with mortality (Fig. 2). Mortality
was 0%, for an Imrie score of 0 or 1, and it gradually
increased to 100%, for patients with an Imrie score of 7
(Ptrend < 0.001). Mortality also increased with increasing
Balthazar grade, although these differences were less pro-
nounced (Ptrend = 0.04) (Fig. 2). The worsening of prog-
nosis with increasing Imrie score and Balthazar grade
was apparent in each separate treatment group. Overall
mortality in the selective decontamination group versus
the mortality in the control group appeared to be signifi-
cantly lower (p = 0.048), using multivariate analysis al-
lowing for Imrie score and Balthazar grade (Table 3).
This analysis also demonstrates the importance of the
Imrie score in predicting mortality. There was no sig-
nificant relation between mortality and the Balthazar
grade.
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DU
n
a 0.50-
.c
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s30 day 60 90
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Balthazar grade
P (trend) = 0.04
30 day 60 90
Figure 2. Survival according to an Imrie score of 0/1 (n = 24), 2 (n = 12),
3 (n = 16), 4 (n = 25), 5 (n = 15), 6 (n = 5), and 7 (n = 5), respectively
(upper panel). Survival according to Balthazar grade C (n = 7), D (n = 41),
or E (n = 53), respectively (lower panel). Both as assessed at entry into
the study, for both treatment groups combined. Severe acute pancreatitis
was defined according to Imrie score 2 3 points and/or CT findings ac-
cording to Balthazar's degree of disease severity grade D or E.
Table 3. MULTIVARIATE ANALYSIS OF
MORTALITY IN RELATION TO TREATMENT,
IMRIE SCORE, AND BALTHAZAR GRADE
Odds
Factor Ratio p Value
Bacteriologic Analysis
Secondary pancreatic infection occurred in 20 pa-
tients (38%) in the control group and in 9 patients (18%)
of the selective decontamination group (p = 0.03).
Gram-negative pancreatic infection occurred in 17 pa-
tients (33%) in the control group and in only 4 patients
(8%) in the selective decontamination group (p = 0.003).
Pancreatic necrosis was not infected in 11 of 16 patients
who died early, in contrast to only 3 of 13 patients who
died after 2 weeks (p = 0.03). This difference is similar
for both groups.
Treatment
Control
Selective decontamination
lmrie score
Balthazar grade
C/D
E
1*
0.3 (0.3)
3.7t (3.9)
1*
1.8 (-)
0.048 (0.049)
< 0.001 (< 0.001)
0.354 (-)
* Reference category.
t Relative to patients who have an lmrie score of 1 point less.
Data given are odds-ratios for mortality. (Odds-ratios > 1 indicate an increased mor-
tality; < 1 indicate a decreased mortality.) Data between parentheses denote results
when only treatment and lmrie score are analysed regarding mortality.
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Table 4. BACTERIOLOGIC ANALYSIS OF
INFECTED NECROSIS PRESENCE OF
MICRO-ORGANISMS*
Selective
Decontamination
Group Control Group
Species (n = 9) (n = 20)
Gram negative aerobic
Acinetobacter spp. - 3
Citrobacter spp. 3
Escherichia coli 1 12
Enterobacter spp. - 5
Klebsiella spp. 1 5
Pseudomonas spp. 3 10
Proteus spp. - 2
Morganella spp. 4
Serratia maresc. 1
Alicaligenes spp. - 1
Gram positive aerobic
Staphylococci spp. - 1
Staph. aureus 4 4
Staph. epidermidis 9 12
Streptococci 2
Enterococci 7 12
Yeasts
Candida albicans 2 10
Micro-organisms may occur in combinations in each separate patient.
Qualitative bacteriologic analysis of (peri-) pancreatic
necrosis for both groups is demonstrated in Table 4. Of
74 bacterial colonies isolated from 20 patients ofthe con-
trol group, 61% were aerobic gram-negative pathogens.
Of28 colonies isolated from nine patients ofthe selective
decontamination group, 21% were aerobic gram-nega-
tive. Any case ofgram-negative pancreatic infection was
preceded by intestinal colonization with identical gram-
negative flora in both groups, as learned from surveil-
lance cultures ofthe digestive tract.
Selective Decontamination Regimen:
Complications and Failure of Selective
Decontamination Because of Resistance
There were no noticeable allergies in the selective de-
contamination regimen, and none of the deaths in the
selective decontamination group were attributable to the
selective decontamination regimen. Oral paste and rectal
enemas were well tolerated. Gram-negative colonization
of the digestive tract was successfully prevented in 46 of
50 patients (92%) of the selective decontamination
group. However, failure of selective decontamination to
prevent gram-negative colonization ofthe digestive tract
with subsequent infection ofpancreatic necrosis with the
same gram-negative bacteria was seen in 4 of 50 patients
(8%). Three ofthese patients died after 9, 37, and 40 days
due to resistant strains ofPseudomonas aeruginosa (two
patients) and Klebsiella (one patient). Escherichia coli
(< 1+) was isolated only once from pancreatic necrosis
in one of these patients at the end of the first week be-
cause of initial persistence ofintestinal E. coli. Transient
gram-negative pancreatic infection during selective de-
contamination treatment was seen in one patient-i.e.,
P. aeruginosa (< 3 days), followed by Serratia marces-
cens (< 18 days)-who was later discharged after 106
days.
Surgery and Surgery-Related Morbidity
In the control group, an average of 3.1 laparotomies
were performed per patient in contrast to only 0.9 in the
selective decontamination group (p < 0.05; Table 5). A
laparostomy, whenever repeated necrosectomy was fore-
seen, was created in 50% of the patients in both groups.
In the control group, surgical complications were seen in
nine patients, compared with four patients of the selec-
tive decontamination group, who had undergone surgery
less frequently (p = 0.50, NS).
Median hospital stay in patients who survived was 30
days (range 10-106 days) in the selective decontamina-
tion group compared with 32 days (range 6-241 days) in
the control group (p = 0.65, NS).
Table 5. SURGERY AND SURGICAL
MORBIDITY
Selective
Decontamination Control
Group Group
(n = 50) (n = 52)
Laparotomy
Laparotomies/patient
(range)
Patients with surgery-related
complications
Complicationst
Small bowel resections
Large bowel resections
Enteric fistulas
Pancreatic fistulas
Splenectomy
16 (32%)
09* (0-17)
4(8%)
0
1
2
2
0
24 (46%)
3.1* (0-29)
9 (17%)
5
7
6
2
3
*p<0.05.
t Complications may occur in combinations in each separate patient. Laparostomies
were created in 8 out of 16 patients in the selective decontamination group and in
12 out of 24 patients in the control group.
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DISCUSSION
The division of acute necrotizing pancreatitis into an
early vasoactive toxic phase and a late phase dominated
by septic complications is widely accepted.9'38-40 Sys-
temic complications during the initial phase of circula-
tory depression, such as myocardial depression and
acute renal and respiratory failure, are thought to be me-
diated by activated pancreatic enzymes and other vaso-
active and toxic agents released from the pancreas and
the peritoneal exudate.38'41'42 Intensive treatment has im-
proved the prognosis with regard to these complications,
which previously were the major cause of death during
the early phase ofacute necrotizing pancreatitis.38'43'44
Secondary infection ofpancreatic necrosis currently is
the most lethal complication of acute necrotizing pan-
creatitis, particularly during the later stages of the dis-
ease.'29-13,1720,38,45 Gram-negative aerobic bacteria, origi-
nating from the digestive tract, are predominantly
isolated from infected pancreatic necrosis.9, 14,1923,26 Re-
cently, Medich et al. reported that acute pancreatitis in
rats promotes translocation ofgastrointestinal organisms
to the inflamed pancreas and peripancreatic region.27
Widdison et al. reported striking results from a feline
model, suggesting gut-derived pancreatic infection by
showing that labeled intestinal E. coli were not recovered
from the site of acute necrotizing pancreatitis when the
colon was enclosed in an impermeable bag that prohib-
ited translocation.22
Until now, the beneficial effect of prophylactic antibi-
otics in acute pancreatitis has been debated.'2"15"'6 Re-
cently, Pederzoli et al. reported that prophylactic treat-
ment with intravenous imipenem significantly reduced
the incidence of infected necrosis (12.2%) as compared
with placebo (30.3%). However, no significant reduction
in mortality could be demonstrated.46 Ifincreased bacte-
rial translocation from the digestive tract is the mecha-
nism leading to pancreatic infection, selective decontam-
ination should, in theory, be useful in preventing pancre-
273 rpreasinfcnatic sepsis. McClelland et al.3' reported a significant
reduction in clinical signs of sepsis in patients with acute
pancreatitis and acute respiratory failure who were
treated with selective decontamination. No significant
reduction in mortality, however, was demonstrated from
this retrospective analysis comprising only six selective
decontamination patients in a 3-year period, who were
compared with nine historic control patients from an
earlier 3-year period. Reduction ofmortality in intensive
care unit patients treated with adjuvant selective decon-
tamination still is a matter of debate,29-34 and random-
ized controlled clinical trials of selective decontamina-
tion in the treatment of patients with severe acute pan-
creatitis currently are not available. In the prospective
clinical trials reported to date, only a few patients had
severe acute pancreatitis or developed pancreatic sepsis.
In the present study, selective decontamination signifi-
cantly (p = 0.003) reduced the incidence of gram-nega-
tive pancreatic sepsis. Consequently, a significant reduc-
tion in the number oflaparotomies having fewer surgery-
related complications occurred in patients treated with
selective decontamination.
Because infection of originally sterile pancreatic ne-
crosis is a secondary phenomenon, effective antibiotic
prophylaxis may result mainly in reduction of late mor-
tality. Early mortality, rather dominated by effects of va-
soactive and toxic agents released from the pancreas and
peritoneal exudate than by septic complications, may
consequently be less reduced by antibiotics.3842 This
may explain why selective decontamination, reducing
total mortality, did not affect early mortality (within 2
weeks) as appeared on further analysis (selective decon-
tamination: 16%; 8/50 patients; control: 15%; 8/52 pa-
tients) (p = 0.71). Late mortality, on the other hand, was
significantly reduced by selective decontamination (se-
lective decontamination: 7%; 3/42 patients; control:
23%; 10/44 patients). In both groups, all gram-negative
pancreatic infections, if present, were preceded by colo-
nization of the digestive tract with the same gram-nega-
tive bacteria. If pancreatic necrosis was infected despite
successful selective decontamination, only gram-posi-
tive aerobic bacteria were isolated, as has also been noted
by others.47 If selective decontamination fails, however,
mortality increases sharply, which has been recognized
earlier in surgical intensive care patients.48
Severity scoring of acute pancreatitis immediately af-
ter admission has previously been strongly advocated to
identify patients at risk.35'36'49-5' It also enables clinicians
to compare treatment results more accurately. Scoring
systems should be accurate but easy to use. The Imrie
score proved to be very valuable in identifying patients
with acute pancreatitis with increased risk of death.
Computed tomography findings, according to Baltha-
zar's degree of disease severity, were less accurate in pre-
dicting prognosis. Total mortality of patients who were
found to have severe acute pancreatitis according CT
findings alone (Balthazar grade D or E, but Imrie score
<3) was less than 5% in each group. These data suggest
that the use ofselective decontamination in such patients
may not result in additional benefit and is cost-inducing.
We conclude that selective decontamination is espe-
cially indicated for patients with severe acute pancreatitis
with an Imrie score 2 3, regardless of the CT findings36
on admission. Treated as such, in this study, total mor-
tality was reduced from 55% (17/31 patients) to 31% (11 /
35 patients), with a 95% confidence interval for the
difference in mortality ranging from 0% to 48%.
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